Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Sunwin International Neutraceuticals, Inc. (SUWN) First Quarter Revenue Explodes

Sunwin International Neutraceuticals, Inc. (SUWN.OB), the $20+ million Chinese natural medicine and herb producer, reported Friday a Q1 (fiscal 2009) revenue increase of 48%, to $6.2 million.

Sunwin’s herbal and medicinal products are largely blended with other products at the wholesale level, and marketed in China and Japan. Sunwin produces over 120 Chinese herbs, along with a variety of natural additives for animal feed. Perhaps their biggest potential market, however, is in the natural sweetener Stevia (Stevioside), produced from the leaves of the Stevia Rebaudiana plant, a bushy member of the Chrysanthemum family. The plant was successfully introduced to China from South America in the 1970s. Stevioside is estimated to be 200-300 times sweeter than general sucrose, while having only 1/300th the calories.

Stevioside has a long history as a food additive in Asia, with no significant health questions like those that have plagued aspartame and other commonly used non-sugar sweeteners. Coca Cola and Pepsi have both been pushing for approval for its use in its beverages. You can also bake with it, opening up a huge range of products for the growing diabetic market.

Sunwin ( works closely with various Chinese research facilities and universities, including China Science Bureau, Shandong Biological Science Institute, China Medical University, Beijing Medical University, Shandong Medical University, and Shandong Agriculture University, for joint research and development efforts, allowing Sunwin to rapidly develop new products.

In 2002, Sunwin received the “State-Level Biological Manufacturer Award” from China’s Bureau of Science and Technology, and the “Top 50 Firms in China’s Animal Health Industry Award” from China’s Animal Health Group Product Association. The company has also received the “Innovative High-Technology Business” and “AAA Highest Reputable Firm” awards.

In addition to the jump in quarterly revenues, Sunwin also reported a cash increase of 29% to $7.7 million, and a book value increase of $.36 per share. SUWN, which sold for over $1.50 in early 2006, closed at .173 Thursday.

Let us hear your thoughts below:

This entry was posted in Small Cap News. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *